Improve Dementia Diagnosis and care with the BrainCheck® CORTEX™ Platform.
The DEMENTIA CARE PLAYBOOK | PoPULATION HEalth
Increase Capitation Payments in 2022
Take advantage of Medicare risk-adjustment by improving dementia diagnosis in your senior patient populations.
Dementia is 50% more costly than heart disease or cancer—and 66% of dementia goes undiagnosed.
In response to growing evidence that early detection improves patient outcomes and reduces cost of care, Medicare has incentivized dementia diagnosis with increased capitation payments and reimbursement codes for cognitive assessment.
Download the Population Health Guide to learn…
– How much revenue you can generate per diagnosis via capitation payments, risk-adjusted for dementia
– The three documentation requirements for risk-adjustment to occur
– How improved dementia diagnosis and care planning can reduce total cost of care—in addition to generating revenue
Does your organization operate a fee-for-service or hybrid payment model?
Learn about Medicare’s FFS reimbursement incentives for cognitive assessment in our reimbursement guide.
Improve Dementia Diagnosis with Cognitive Testing at the Point of Care
The BrainCheck CORTEX platform brings the diagnostic power of neuropsychological testing to the point of care.
BrainCheck assessments are clinically-validated, gamified assessments that take less than 15 minutes to complete. They can be administered in clinic by a technician or taken remotely by the patient in their own home—saving physician time and increasing access to a timely diagnosis and proper cognitive care.
Get Proven Results
Study Demonstrates How BrainCheck Benefits Health Systems
BrainCheck conducted a pilot study with Hartford Healthcare to measure the platform’s ability to improve care and reduce costs. Four providers (representing primary care, geriatrics and neurology), administered 60 cognitive assessments using the platform, demonstrating:
Excellent System Usability Score
With an even split between in-clinic and remote cognitive assessments, BrainCheck received an average system usability score of 85 from providers, which is considerably higher than the industry average of 68 and puts the platform in the 95th percentile for software products. And 80% of patients said they were satisfied with their experience despite the fact that many were diagnosed with dementia.
Added Diagnostic Confidence
Following administration of BrainCheck, the providers at Hartford Healthcare saw an increase in triggering of appropriate further work up in both laboratory tests and imaging — 83% and 50% increases respectively.
Increased Specificity of Diagnosis
BrainCheck increased the specificity of diagnosis from 28% specific prior to using Braincheck to 68% specific with BrainCheck. BrainCheck gives physicians the ability to distinguish dementia from other treatable conditions and offer reassurance to those with subjective memory loss.
“We have an imperative to screen for and identify cognitive impairment.”
— Dr. Robert Dicks | Chief of Geriatric Medicine, Hartford Hospital 
